Angiogenic Resorcinol Derivatives

Novel resorcinol derivatives and methods of preparation and use are presented. These compounds can stimulate angiogenesis as a biological function triggered by the activation of one cannabinoid receptor distinct from CB1 and CB2. Thus, these compounds are specific ligands for one cannabinoid receptor distinct from CB1 and CB2. The invented compounds, when administered in a therapeutically effective amount to an individual or animal, results in a sufficiently high level of that compound in the individual or animal to cause a physiological response. The physiological response may be useful to treat a number of physiological conditions.

Attached files:


Patents:
WO 2,011,006,099

Inventor(s): MAKRIYANNIS ALEXANDROS [US]; NIKAS SPYRIDON P [US]; ALAPAFUJA SHAKIRU O [US]

Type of Offer: Licensing



« More Medical Patents

---